were trialed on significantly higher doses of tofacitinib (15-22 mg once daily) with only one patient unresponsive to both high and low dose treatment (15 mg once daily). This suggests that if no growth is seen after 3 months, the patient may be aSuccessful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib
July 2018 | Volume 17 | Issue 7 | Case Reports | 800 | Copyright © July 2018
Michelle W. Cheng BS,a Amy Kehl MD,b Scott Worswick MD,a Carolyn Goh MDa
aDavid Geffen School of Medicine UCLA, Los Angeles, CA bUCLA, Los Angeles, CA
were trialed on significantly higher doses of tofacitinib (15-22 mg once daily) with only one patient unresponsive to both high and low dose treatment (15 mg once daily). This suggests that if no growth is seen after 3 months, the patient may be a
